CIANCIUSI, ANNARITA
 Distribuzione geografica
Continente #
EU - Europa 740
AS - Asia 225
NA - Nord America 119
SA - Sud America 7
AF - Africa 2
Totale 1.093
Nazione #
IT - Italia 709
US - Stati Uniti d'America 116
SG - Singapore 67
CN - Cina 44
HK - Hong Kong 35
JP - Giappone 35
VN - Vietnam 22
TW - Taiwan 10
FR - Francia 9
KR - Corea 6
DE - Germania 5
BR - Brasile 4
ES - Italia 4
GB - Regno Unito 4
CH - Svizzera 2
FI - Finlandia 2
ID - Indonesia 2
MX - Messico 2
SA - Arabia Saudita 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CA - Canada 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
IN - India 1
LV - Lettonia 1
NL - Olanda 1
RU - Federazione Russa 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 1.093
Città #
Genoa 467
Vado Ligure 101
Rapallo 87
Genova 45
San Jose 36
Singapore 29
Tokyo 29
Ashburn 19
New York 15
Council Bluffs 11
Beijing 10
Hong Kong 9
Lauterbourg 9
Ho Chi Minh City 8
Hanoi 6
Taipei 5
Frankfurt am Main 4
Los Angeles 4
Seattle 4
Dobong-gu 3
Ha Kwai Chung 3
Haiphong 3
Richardson 3
Andria 2
Chai Wan 2
Cheung Sha Lan 2
Chicago 2
Helsinki 2
Jakarta 2
Phoenix 2
Seoul 2
Tukwila 2
Algiers 1
Amsterdam 1
Bogotá 1
Borlänge 1
Brantford 1
Brooklyn 1
Bắc Ninh 1
Cadiz 1
Cedar Knolls 1
Charlotte 1
City of London 1
Copertino 1
Da Nang 1
Dammam 1
Dortmund 1
Draper 1
Fremont 1
Geneva 1
Guangzhou 1
Jacksonville 1
Jeddah 1
Johannesburg 1
Jundiaí 1
Kowloon City 1
Kwai Chung 1
Limoeiro do Norte 1
Madrid 1
Mexico City 1
Milan 1
New Delhi 1
Nova Lima 1
Palma 1
Posadas 1
Queenstown Estate 1
Quito 1
Riga 1
Rome 1
Salt Lake City 1
Santa Clara 1
Santa Inês 1
Scandicci 1
Shenzhen 1
St Petersburg 1
Villa de Zaachila 1
Villacidro 1
Xi'an 1
Yuanlin 1
Zhongli District 1
Zurich 1
Totale 977
Nome #
SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW 4-AMINO-PYRAZOLO[3,4-d]PYRIMIDINES AS POTENTIAL SRC KINASE INHIBITORS 192
Identification and Biological Characterization of the Pyrazolo[3,4-d]pyrimidine Derivative SI388 Active as Src Inhibitor 98
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 92
4,6-Diphenyl-pyridines/pyrimidines and pyrazolo[3,4-d]pyrimidines: promising scaffolds as antiviral, anticancer and theranostic agents. 92
Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction 87
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma 85
Synthesis of a new series of optimized pyrazolo[3,4‑d]pyrimidines as Src Inhibitors 78
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma 75
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment 68
Synthesis of hybrid small molecules as potential PA-PB1 heterodimer disruptors of Influenza virus Polymerase 68
Development of a new potential theranostic prodrug for targeting glioblastoma multiforme 65
New potential anti-flu agents acting by disrupting the PA-PB1 interaction of viral polymerase. 62
Synthesis of a new generation of potential anti-influenza agents targeting the PA-PB1 protein-protein interaction. 59
Totale 1.121
Categoria #
all - tutte 4.050
article - articoli 1.907
book - libri 0
conference - conferenze 1.804
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 0 0 0 8 4 14 14 3 2 6
2022/2023117 8 0 1 1 10 16 0 7 18 12 33 11
2023/2024146 6 7 3 24 22 8 12 7 8 18 19 12
2024/2025261 3 19 10 4 37 41 23 45 5 20 23 31
2025/2026546 48 10 74 19 79 59 109 53 45 50 0 0
Totale 1.121